Hsp72, inflammation, and aging: Causes, consequences, and perspectives

Annals of the New York Academy of Sciences

Volumn 1261, Issue 1, 2012, Pages 64-71

  Ortega, Eduardo ^a   Bote, María Elena ^a   Besedovsky, Hugo Oscar ^b   Rey, Adriana del ^b  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Hsp70; Innate response; Longevity; Neuro immune endocrine interactions; Stress

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; HEAT SHOCK PROTEIN 72; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADRENERGIC SYSTEM; AGING; ARTICLE; BEHAVIOR; BRAIN FUNCTION; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOCRINE SYSTEM; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LONGEVITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS;

EID: 84864103780     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06619.x     Document Type: Article

References (83)

1. Lindquist, S. & E.A. Craig. 1988. The heat-shock proteins. Ann. Rev. Genet. 22: 631-677.
2. Asea, A. 2005. Stress proteins and initiation of immune response: chaperokine activity of hsp72. Exerc. Immunol. Rev. 11: 34-45.
3. Fleshner, M. et al. 2004. Cat exposure induces both intra- and extracellular Hsp72: the role of adrenal hormones. Psychoneuroendocrinology 29: 1142-1152.
4. Lindquist, S. 1986. The heat-shock response. Annu. Rev. Biochem. 55: 1151-1191.
5. Asea, A. 2007. Hsp72 release: mechanisms and methodologies. Methods 43: 194-198.
6. Clayton, A. et al. 2005. Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 118: 3631-3638.
7. Giraldo, E., G. Multhoff & E. Ortega. 2010. Noradrenaline increases the expression and release of Hsp72 by human neutrophils. Brain Behav. Immun. 24: 672-677.
8. Hunter-Lavin, C. et al. 2004. Hsp70 release from peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 324: 511-517.
9. Giraldo, E. et al. 2008. Influence of gender and oral contraceptives intake on innate and inflammatory response. Role of neuroendocrine factors. Mol. Cell Biochem. 313: 147-153.
10. Pockley, A.G., J. Shepherd & J.M. Corton. 1998. Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol. Invest. 27: 367-377.
11. Campisi, J., T.H. Leem & M. Fleshner. 2003. Stress-induced extracellular Hsp72 is a functionally significant danger signal to the immune system. Cell Stress Chaperones 8: 272-286.
12. Pockley, A.G. et al. 2002. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens. 20: 1815-1820.
13. Pockley, A.G. et al. 2003. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42: 235-238.
14. Ortega, E. et al. 2009. The effect of stress-inducible extracellular Hsp72 on human neutrophil chemotaxis: a role during acute intense exercise. Stress 12: 240-249.
15. Johnson, J.D. et al. 2005. Adrenergic receptors mediate stress-induced elevations in extracellular Hsp72. J. Appl. Physiol. 99: 1789-1795.
16. Asea, A. et al. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6: 435-442.
17. Asea, A. et al. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277: 15028-15034.
18. Giraldo, E. et al. 2010. Exercise-induced extracellular 72 kDa heat shock protein (Hsp72) stimulates neutrophil phagocytic and fungicidal capacities via TLR-2. Eur. J. Appl. Physiol. 108: 217-225.
19. Hinchado, M.D., E. Giraldo & E. Ortega. 2012. Adrenoreceptors are involved in the stimulation of neutrophils by exercise-induced circulating concentrations of Hsp72: cAMP as a potential "intracellular danger signal." J. Cell. Physiol. 227: 604-608.
20. Ortega, E. et al. 2006. Role of Hsp72 and norepinephrine in the moderate exercise-induced stimulation of neutrophils' microbicide capacity. Eur. J. Appl. Physiol. 98: 250-255.
21. Wang, R. et al. 2006. HSP70 enhances macrophage phagocytosis by interaction with lipid raft-associated TLR-7 and upregulating p38 MAPK and PI3K pathways. J. Surg. Res. 136: 58-69.
22. Fleshner, M., J. Campisi & J.D. Johnson. 2003. Can exercise stress facilitate innate immunity? A functional role for stress-induced extracellular Hsp72. Exer. Immunol. Rev. 9: 6-24.
23. Besedovsky, H.O. & A. del Rey. 2007. Physiology of psychoneuroimmunology: a personal view. Brain Behav. Immun. 21: 34-44.
24. De la Fuente, M. & J. Miquel. 2009. An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging. Curr. Pharm. Design 15: 3003-3026.
25. Fabris, N. 1991. Neuroendocrine-immune interactions: a theoretical approach to aging. Arch. Gerontol. Geriat. 12: 219-230.
26. Pawelec, G. 1995. Molecular and cell biological studies of ageing and their application to considerations of T lymphocyte immunosenescence. Mech. Ageing Dev. 79: 1-32.
27. Pawelec, G. et al. 1995. Immunosenescence: ageing of the immune system. Immunol. Today 16: 420-422.
28. Vellas, B.J., J.-L. Albaréde & P.J. Garry. 1993. Facts and Research in Gerontology, Vol. 7. J.L. Albarède, P.J. Garry & P. Vellas, Eds.: 23-29. Serdi. Paris.
29. Ortega, E. et al. 1992. Effect of physical activity stress on the phagocytic process of peritoneal macrophages from old guinea pigs. Mech. Ageing Dev. 65: 157-165.
30. Fagiolo, U. et al. 1993. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23: 2375-2378.
31. Ortega, E., J.J. Garcia & M. De La Fuente. 2000. Ageing modulates some aspects of the non-specific immune response of murine macrophages and lymphocytes. Exp. Physiol. 85: 519-525.
32. Ortega, E. et al. 2000. Changes with aging in the modulation of macrophages by norepinephrine. Mech. Ageing Dev. 118: 103-114.
33. Arranz, L. et al. 2010. Differential expression of Toll-like receptor 2 and 4 on peritoneal leukocyte populations from long-lived and non-selected old female mice. Biogerontology 11: 475-482.
34. Franceschi, C. 2007. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr. Rev. 65: S173-176.
35. Franceschi, C. et al. 2000. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908: 244-254.
36. Franceschi, C. et al. 2007. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128: 92-105.
37. Harman, D. 1956. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11: 298-300.
38. Kulinsky, V.I. 2007. Biochemical aspects of inflammation. Biochemistry 72: 595-607.
39. Miquel, J. et al. 2009. In Actualizaciones En Aspectos Básicos Y Clínicos Del Envejecimiento Y La Fragilidad. L. Rodríguez, Ed.: 143-166. Novartis. Madrid.
40. Jin, X. et al. 2004. Serum and lymphocyte levels of heat shock protein 70 in aging: a study in the normal Chinese population. Cell Stress Chaperones 9: 69-75.
41. Njemini, R. et al. 2011. Circulating heat shock protein 70 in health, aging and disease. BMC Immunology 12: 24.
42. Njemini, R., C. Demanet & T. Mets. 2004. Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during aging. Biogerontology 5: 31-38.
43. Rea, I.M., S. McNerlan & A.G. Pockley. 2001. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp. Gerontol. 36: 341-352.
44. Terry, D.F. et al. 2004. Cardiovascular disease delay in centenarian offspring: role of heat shock proteins. Ann. N.Y. Acad. Sci. 1019: 502-505.
45. Terry, D.F. et al. 2006. Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech. Ageing Dev. 127: 862-868.
46. Chiu, H.Y., L.Y. Tsao & R.C. Yang. 2009. Heat-shock response protects peripheral blood mononuclear cells (PBMCs) from hydrogen peroxide-induced mitochondrial disturbance. Cell Stress Chaperones 14: 207-217.
47. Tang, D. et al. 2007. Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J. Immunol. 178: 7376-7384.
48. Volloch, V. & S. Rits. 1999. A natural extracellular factor that induces Hsp72, inhibits apoptosis, and restores stress resistance in aged human cells. Exp. Cell Res. 253: 483-492.
49. Xu, L. et al. 2010. Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia 58: 1042-1049.
50. Gupte, A.A., G.L. Bomhoff & P.C. Geiger. 2008. Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J. Appl. Physiol. 105: 839-848.
51. Gupte, A.A. et al. 2011. Acute heat treatment improves insulin-stimulated glucose uptake in aged skeletal muscle. J. Appl. Physiol. 110: 451-457.
52. Luo, X. et al. 2008. Release of heat shock protein 70 and the effects of extracellular heat shock protein 70 on the production of IL-10 in fibroblast-like synoviocytes. Cell Stress Chaperones 13: 365-373.
53. Mozo, L., A. Suarez & C. Gutierrez. 2004. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin. Exp. Allergy 34: 406-412.
54. Verhoef, C.M. et al. 1999. The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production. Ann. Rheum. Dis. 58: 49-54.
55. Elenkov, I.J. & G.P. Chrousos. 2002. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 966: 290-303.
56. Forner, M.A. et al. 1995. A study of the role of corticosterone as a mediator in exercise-induced stimulation of murine macrophage phagocytosis. J. Physiol. 488: 789-794.
57. Ortega, E., M.A. Forner & C. Barriga. 1997. Exercise-induced stimulation of murine macrophage chemotaxis: role of corticosterone and prolactin as mediators. J. Physiol. 498: 729-734.
58. Besedovsky, H. et al. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233: 652-654.
59. Besedovsky, H.O. et al. 1991. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J. Steroid Biochem. Mol. Biol. 40: 613-618.
60. del Rey, A. et al. 1987. Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit. Ann. N.Y. Acad. Sci. 496: 85-90.
61. Besedovsky, H.O. & A. del Rey. 2006. Regulating inflammation by glucocorticoids. Nat. Immunol. 7: 537.
62. Sun, L. et al. 2000. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am. J. Physiol. Heart Circ. Physiol. 278: H1091-H1097.
63. Campisi, J. et al. 2003. Habitual physical activity facilitates stress-induced HSP72 induction in brain, peripheral, and immune tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284: R520-R530.
64. Ortega, E. et al. 2011. Altered Hsp72-induced release of inflammatory cytokines and circulating levels of Hsp72, glucose, and corticosterone during aging. Neuroimmunomodulation 18: 395.
65. Murlasits, Z. et al. 2006. Resistance training increases heat shock protein levels in skeletal muscle of young and old rats. Exp. Gerontol. 41: 398-406.
66. Simar, D. et al. 2004. Effect of age on Hsp72 expression in leukocytes of healthy active people. Exp. Gerontol. 39: 1467-1474.
67. Besedovsky, H.O. & A. del Rey. 2011. Central and peripheral cytokines mediate immune-brain connectivity. Neurochem. Res. 36: 1-6.
68. del Rey, A. et al. 2006. IL-1 resets glucose homeostasis at central levels. Proc. Natl. Acad. Sci. U.S.A. 103: 16039-16044.
69. Besedovsky, H.O. & A. del Rey. 2010. Interleukin-1 resets glucose homeostasis at central and peripheral levels: relevance for immunoregulation. Neuroimmunomodulation 17: 139-141.
70. del Rey, A. & H. Besedovsky. 1989. Antidiabetic effects of interleukin 1. Proc. Natl. Acad. Sci. U.S.A. 86: 5943-5947.
71. Matsuki, T. et al. 2003. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J. Exp. Med. 198: 877-888.
72. Somm, E. et al. 2005. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 54: 3503-3509.
73. de Roos, B. et al. 2009. Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9: 3244-3256.
74. Perrier, S., F. Darakhshan & E. Hajduch. 2006. IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett. 580: 6289-6294.
75. Chung, J. et al. 2008. HSP72 protects against obesity-induced insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 105: 1739-1744.
76. Balschun, D. et al. 2003. Hippocampal interleukin-1 beta gene expression during long-term potentiation decays with age. Ann. N.Y. Acad. Sci. 992: 1-8.
77. Balschun, D. et al. 2004. Interleukin-6: a cytokine to forget. FASEB J. 18: 1788-1790.
78. Goshen, I. et al. 2009. Environmental enrichment restores memory functioning in mice with impaired IL-1 signaling via reinstatement of long-term potentiation and spine size enlargement. J. Neurosci. 29: 3395-3403.
79. Goshen, I. et al. 2007. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 32: 1106-1115.
80. Schneider, H. et al. 1998. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U.S.A. 95: 7778-7783.
81. Giffard, R.G. & M.A. Yenari. 2004. Many mechanisms for hsp70 protection from cerebral ischemia. J. Neurosurg. Anesthesiol. 16: 53-61.
82. Lin, Y.W. et al. 2004. Heat-shock pretreatment prevents suppression of long-term potentiation induced by scopolamine in rat hippocampal CA1 synapses. Brain Res. 999: 222-226.
83. Nickerson, M. et al. 2005. Physical activity alters the brain Hsp72 and IL-1beta responses to peripheral E. coli challenge. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R1665-R1674.